[Osteoporotic fracture in menopausal women: alendronate reduces the risk]

Rev Med Suisse. 2008 Dec 10;4(183):2703.
[Article in French]
No abstract available

MeSH terms

  • Alendronate / administration & dosage
  • Alendronate / adverse effects
  • Alendronate / therapeutic use*
  • Bone Density Conservation Agents / administration & dosage
  • Bone Density Conservation Agents / adverse effects
  • Bone Density Conservation Agents / therapeutic use*
  • Female
  • Fractures, Bone / prevention & control*
  • Hip Fractures / prevention & control
  • Humans
  • Middle Aged
  • Osteoporosis, Postmenopausal / complications
  • Osteoporosis, Postmenopausal / drug therapy*
  • Primary Prevention
  • Risk Factors
  • Secondary Prevention
  • Spinal Fractures / prevention & control

Substances

  • Bone Density Conservation Agents
  • Alendronate